BAS
FBT icon

Brown Advisory Securities’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Brown Advisory Securities’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,905
Closed -$384K – 20
2022
Q3 		$384K Sell
2,905
-3,200
-52% -$449K 1.4% 28
2022
Q2 		$829K Sell
6,105
-1,740
-22% -$240K 0.78% 36
2022
Q1 		$1.17M Sell
7,845
-2,135
-21% -$316K 0.69% 36
2021
Q4 		$1.62M Sell
9,980
-1,210
-11% -$196K 0.69% 33
2021
Q3 		$1.86M Sell
11,190
-750
-6% -$128K 0.55% 46
2021
Q2 		$2.06M Hold
11,940
– – 0.32% 60
2021
Q1 		$1.92M Sell
11,940
-675
-5% -$116K 0.33% 60
2020
Q4 		$2.12M Sell
12,615
-150
-1% -$24.3K 0.36% 56
2020
Q3 		$2.01M Sell
12,765
-1,000
-7% -$163K 0.41% 52
2020
Q2 		$2.38M Sell
13,765
-1,200
-8% -$188K 0.51% 45
2020
Q1 		$2.03M Hold
14,965
– – 0.52% 49
2019
Q4 		$2.23M Sell
14,965
-63
-0.4% -$8.65K 0.53% 45
2019
Q3 		$1.86M Sell
15,028
-300
-2% -$39.9K 0.52% 47
2019
Q2 		$2.15M Sell
15,328
-575
-4% -$79.3K 0.57% 44
2019
Q1 		$2.4M Buy
15,903
+350
+2% +$50.4K 0.56% 49
2018
Q4 		$1.93M Sell
15,553
-400
-3% -$54.7K 0.37% 64
2018
Q3 		$2.53M Sell
15,953
-87
-0.5% -$13.2K 0.41% 59
2018
Q2 		$2.25M Sell
16,040
-1,325
-8% -$182K 0.39% 63
2018
Q1 		$2.31M Buy
17,365
+25
+0.1% +$3.41K 0.43% 59
2017
Q4 		$2.16M Sell
17,340
-200
-1% -$24.7K 0.42% 60
2017
Q3 		$2.17M Buy
17,540
+165
+0.9% +$19.5K 0.47% 58
2017
Q2 		$1.98M Buy
17,375
+2,700
+18% +$290K 0.45% 56
2017
Q1 		$1.55M Buy
14,675
+8,550
+140% +$857K 0.38% 71
2016
Q4 		$556K Sell
6,125
-200
-3% -$18.7K 0.15% 155
2016
Q3 		$632K Buy
6,325
+2,225
+54% +$218K 0.18% 126
2016
Q2 		$367K Hold
4,100
– – 0.11% 186
2016
Q1 		$359K Hold
4,100
– – 0.12% 175
2015
Q4 		$465K Buy
+4,100
New +$441K 0.16% 153
2015
Q3 		– Sell
-1,925
Closed -$240K – 320
2015
Q2 		$240K Hold
1,925
– – 0.08% 254
2015
Q1 		$229K Buy
+1,925
New +$218K 0.08% 249

Other funds holding FBT

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
BFG
Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

Brown Advisory Securities's FBT Position: Q4 2022 in Review

Brown Advisory Securities sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q4 2022, closing a stake of 2,905 shares — an estimated $384K sold.

Brown Advisory Securities first reported a position in FBT in Q1 2015 and held it in 30 quarters. The position peaked at $2.53M in Q3 2018. 243 funds tracked by Wall St. Rank hold FBT as of Q4 2022.

  • Brown Advisory Securities reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q4 2022 after selling out during the quarter.
  • Brown Advisory Securities sold 2,905 First Trust NYSE Arca Biotechnology Index Fund shares in Q4 2022, an estimated $384K.
  • Brown Advisory Securities first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2015 and held it in 30 quarters.
  • Brown Advisory Securities's First Trust NYSE Arca Biotechnology Index Fund position peaked at $2.53M in Q3 2018.
  • 243 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q4 2022.

Based on Brown Advisory Securities's 13F filing for Q4 2022.